Nuriplan Co., Ltd. (KOSDAQ:069140)
2,165.00
-60.00 (-2.70%)
At close: Apr 30, 2026
Nuriplan Revenue
In the year 2025, Nuriplan had annual revenue of 117.64B KRW with 1.36% growth. Nuriplan had revenue of 30.07B in the quarter ending December 31, 2025, a decrease of -13.49%.
Revenue
117.64B
Revenue Growth
+1.36%
P/S Ratio
0.28
Revenue / Employee
2.40B
Employees
49
Market Cap
32.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 117.64B | 1.58B | 1.36% |
| Dec 31, 2024 | 116.06B | -6.12B | -5.01% |
| Dec 31, 2023 | 122.18B | -8.97B | -6.84% |
| Dec 31, 2022 | 131.15B | -1.64B | -1.24% |
| Dec 31, 2021 | 132.80B | -6.56B | -4.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Global SM Tech | 124.63B |
| Jeong Moon Information. | 89.80B |
| NARA CELLAR | 82.11B |
| LMS Co., Ltd. | 69.57B |
| Seoul Pharma | 52.15B |
| SANGBO | 50.11B |
| Logisys | 48.54B |
| CU Medical Systems | 48.22B |